Clinical Trial Update: 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 68Ga-PSMA PET-CT for diagnosis and management of prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA PET/CT (68Ga-PSMA PET/CT imaging agent)

Snippet

Sponsor: Ebrahim Delpassand | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN